George Q. Daley, M.D., Ph.D., Associate Professor of Biological Chemistry and Molecular Pharmacology, Children’s Hospital, Harvard Stem Cell Institute; Dan W. Brock, Ph.D., Professor of Medical Ethics, Harvard Medical School; Rudolf Jaenisch, M.D. Member, Whitehead Institute for Biomedical Research, and Professor of Biology, Massachusetts Institute of Technology. Moderated by Gregory D. Curfman, M.D., Executive Editor, New England Journal of Medicine.
Thursday, May 4, 2006 at 6:30 p.m.
Old South Meeting House
Few topics have touched so many areas as stem cell research. It has stirred politics, medicine, business, economics, and religion. It presents much promise – from curing or easing disease and disability, to creating jobs that can energize state economies, to providing financial windfalls for investors. All of that holds great potential, but is surrounded by huge ethical and legal considerations. Where will the road lead? In a program co-sponsored by the Massachusetts Medical Society, medical experts examine two critical aspects of stem cell research: its medical promise and its ethical considerations.
